Abstract
Bacteriostatic and bactericidal activites of amoxicillin, pefloxacin, ofloxacin, ciprofloxacin, sparfloxacin, vancomycin, alone or associated with gentamicin, were evaluated over 22 months using time-kill and combination experiments, on 20 clinicalEnterococcus isolates (6E. faecium and 14E. faecalis) selected in a French district hospital. Sparfloxacin or ciprofloxacin were more frequently bacteriostatic or bactericidal than pefloxacin or ofloxacin but, unlike amoxicillin or vancomycin, the association with gentamicin was not synergistic in most cases and antagonisms were observed in some cases. These results suggest that the use of sparfloxacin or ciprofloxacin could be considered in some cases of infections withEnterococcus that are resistant to penicillins and glycopeptides and/or highly resistant to aminoglycosides. Despite Perri's report to the contrary, the effect of quinolones and gentamicin in combination use was not only synergistic but antagonistic, and we are alerting others to the possible antagonism involved.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Herman DJ, Gerding DM. Screening and treatment of infections caused by resistant enterococci. Antimicrob Agents Chemother 1991;35:215–219.
Zaman M, Landman D, Burney S, Quale JM. Treatment of experimental endocarditis due to multidrug-resistantEnterococcus faecium with clinafloxacin and penicillin. J Antimicrob Chemother 1996;37:127–132.
Perri MB, Chow JW, Zervos MJ. In vitro activity of sparfloxacin and clinafloxacin against multidrug-resistant enterococci. Diagn Microbiol Infect Dis 1993;17:151–155.
Chin NX, Gu JW, Yu KW, Zhang YX, Neu HC. In vitro activity of sparfloxacin. Antimicrob Agents Chemother 1991;35:567–571.
Courvalin, P, Goldstein F, Philippon A, Sirot J (eds). L'antibiogramme: Paris: MPC/Vigot, 1985.
Acar J, Chardon H, Choutet P, Courvalin P, Dabernat H, Drugeon H, et al. Comité de l'Antibiogramme de la Société Française de Microbiologie. Communiqué 1995. Path Biol (Paris) 1995;43(8):I-VIII.
Schulz JE, Sham DF. Reliability of the E-test for detection of ampicillin, vancomycin, and high-level amino-glycoside resistance inEnterococcus spp. J Clin Microbiol 1993;31:3336–3339.
Dutka-Malen S, Courvalin P. Résistance aux glycopeptides et aux aminosides chez les entérocoques. Méd Mal Infect 1994;Spécial 24:158–164.
Gutmann L. Résistance des entérocoques aux β-lactamines et conséquences sur les synergies. Méd Mal Infect 1994;Spécial 24:165–171.
Hooper DC, Quinolones. In: Mandell GL, Bennett JE, Dolin R (eds). Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995:364–376.
Neu HC. Synergy of fluoroquinolones with other antimicrobial agents. Rev Infect Dis 1989;11 (suppl 5):S1025-S1035.
Watine J, Martorell J, Bruna T, Gineston JL, Poirier JL, Lamblin G. In vivo pefloxacin-resistantCampylobacter fetus responsible for gastro-intestinal infection and bacteremia associated with arthritis of the hip. Yonsei Med J 1995;36:202–205.
Moreau N. In: Courvalin P, Drugeon H, Flandrois JP, Goldstein F (eds). Bactéridie. Paris: Maloine, 1990:35–47.
Spratt BG. Resistance to antibiotics mediated by target alterations. Science 1994;264:388–393.
Pérez-Trallero E, Garcia-Arenzana JM, Jimenez JA, Peris A. Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin. Eur J Clin Microbiol Infect Dis 1990;9: 905–906.
Author information
Authors and Affiliations
About this article
Cite this article
Watine, J., Seigneuric, B. & Charet, JC. In vitro quinolone-gentamicin antagonism demonstrated by time-kill and combination experiments with clinical isolates ofEnterococcus . J Infect Chemother 3, 55–57 (1997). https://doi.org/10.1007/BF02489185
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02489185